2014
DOI: 10.3109/14756366.2013.871007
|View full text |Cite
|
Sign up to set email alerts
|

Potential pancreatic lipase inhibitory activity of an endophyticPenicilliumspecies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 21 publications
1
16
1
Order By: Relevance
“…In this context, we chose to evaluate both the anti-obesity and antidiabetic property of the in vitro raised Stevia plant. The study was focussed on inhibition of two enzymes, viz., pancreatic lipase and α-amylase for anti-obesity and antidiabetic property, respectively [1,4]. The lipase inhibitory property of the methanolic extract of in vitro raised Stevia plant (IC 50 =5.74 µg/ml) in this study was found to be much better than that observed in Stevia (IC 50 =530 µg/ml) [21].…”
Section: Discussionmentioning
confidence: 75%
See 3 more Smart Citations
“…In this context, we chose to evaluate both the anti-obesity and antidiabetic property of the in vitro raised Stevia plant. The study was focussed on inhibition of two enzymes, viz., pancreatic lipase and α-amylase for anti-obesity and antidiabetic property, respectively [1,4]. The lipase inhibitory property of the methanolic extract of in vitro raised Stevia plant (IC 50 =5.74 µg/ml) in this study was found to be much better than that observed in Stevia (IC 50 =530 µg/ml) [21].…”
Section: Discussionmentioning
confidence: 75%
“…In vitro pancreatic lipase inhibitory activity was evaluated using a slight modified protocol described by Gupta et al [1]. Varying concentrations…”
Section: Dose Response Activity Of Methanolic Extract Of Stevia Againmentioning
confidence: 99%
See 2 more Smart Citations
“…Mahiti Gupta [20] Pancreatic lipase (PL) is considered as one of the safest target for dietinduced anti-obesity drug development. Orlistat is the only PL inhibitor approved for antiobesity treatment till date.…”
Section: World Journal Of Pharmacy and Pharmaceutical Sciencesmentioning
confidence: 99%